Cite
HARVARD Citation
Miller, R. et al. (n.d.). 2022-RA-1276-ESGO Pembrolizumab monotherapy for advanced clear cell gynaecological cancer: phase II PEACOCC trial. International journal of gynecological cancer. p. A316. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Miller, R. et al. (n.d.). 2022-RA-1276-ESGO Pembrolizumab monotherapy for advanced clear cell gynaecological cancer: phase II PEACOCC trial. International journal of gynecological cancer. p. A316. [Online].